Patent: 9,505,754
✉ Email this page to a colleague
Summary for Patent: 9,505,754
Title: | Compound useful for the treatment of degenerative and inflammatory diseases |
Abstract: | A compound is disclosed that has a formula represented by the following: ##STR00001## This compound may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, inflammatory conditions, autoimmune diseases, proliferative diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6. |
Inventor(s): | Menet; Christel Jeanne Marie (Mechelen, BE), Blanc; Javier (Mechelen, BE) |
Assignee: | GALAPAGOS NV (Mechelen, BE) |
Application Number: | 14/451,127 |
Patent Claims: | see list of patent claims |
Details for Patent 9,505,754
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | 11/26/1997 | ⤷ Try a Trial | 2029-06-26 |
Idec Pharmaceuticals Corp. | RITUXAN | rituximab | Injection | 103737 | 02/19/2002 | ⤷ Try a Trial | 2029-06-26 |
Janssen Biotech, Inc. | REMICADE | infliximab | For Injection | 103772 | 08/24/1998 | ⤷ Try a Trial | 2029-06-26 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |